Genesis Therapeutics
Burlingame, USWebsite
Company-aware practice
Start company interviewLoading company information...
Company context
Genesis Therapeutics prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
Genesis Therapeutics is a biotechnology company at the forefront of AI-driven drug discovery, specializing in the development of small-molecule therapeutics for challenging, 'undruggable' protein targets. Founded in 2019 by Evan Feinberg and Ben Sklaroff, the company emerged from pioneering research at Stanford University's Pande Lab. By integrating advanced deep learning with biophysical simulation, Genesis aims to transform the traditional drug discovery process into a more efficient, multi-parameter optimization problem.
To unify AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions, particularly by targeting 'undruggable' proteins.
Founded
2019
Headquarters
Burlingame, California
Employees
100-200
Industry
Biotechnology
Opportunity to work at the intersection of cutting-edge AI and drug discovery
Strong financial backing and stability from top-tier venture capital firms
High pressure environment typical of early-stage, high-stakes biotech startups
Limited public information regarding internal culture and employee benefits
Funding
Over $300 million
CEO
Evan Feinberg